Status:
UNKNOWN
Treatment of BV With First Deqularum and Then Direkt After Clindamycin
Lead Sponsor:
Skaraborg Hospital
Conditions:
Infection, Bacterial
Eligibility:
FEMALE
18-45 years
Phase:
PHASE3
Brief Summary
Treatment of BV with first deqularum cloride and then followed with clindamycin vaginal Cream.
Detailed Description
The hypoteses is that deqularum cloride takes away the biofilm so that clindamycin will kills the bacteria. Cure rate will be followed up after 1 month and then after 6 month
Eligibility Criteria
Inclusion
- healthy women with BV
Exclusion
- women treated with antibiotics within 1 month
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04067531
Start Date
August 1 2020
End Date
December 1 2021
Last Update
October 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ob/Gyn, Skaraborgshospital Skövde
Skövde, Sweden, 541 85